Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
Ann Ig ; 29(1): 73-85, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28067940

RESUMO

INTRODUCTION: This study of the geographical incidence on the oncological mortality in young age (0-44 years) in the City of Vercelli, was aimed to address the concerns of the population and the request of municipal administrators. A detailed and sophisticated study for a City of medium-small size is due for the presence of various sources of pressure, such as a MSW incinerator just a few kilometres from the city and an intensive agricultural activity that characterizes the entire area. MATERIALS AND METHODS: The study is based on the census analysis of the population, and of the hospital admission cards, and it considers epidemiological standardized estimators and spatial analysis through Bayesian models, as well. RESULTS: Both approaches highlight Major risks for the area south of the city for major tumours such as total cancer in women (SIR / SMR significant excess of about 50%), colorectal (mean increments SMR / SIR between 3 and 4 times), ovary (mean increments SMR / SIR between 3:04 and times), and nervous system (increases 3 times for both indicators). CONCLUSION: These results deserve further studies through inferential case-control and cohort analysis, given the marginal role of the possible occupational hazards in the aetiology of juvenile cancer disorders.


Assuntos
Exposição Ambiental/efeitos adversos , Incineração , Neoplasias/epidemiologia , Neoplasias/etiologia , População Urbana/estatística & dados numéricos , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Itália/epidemiologia , Masculino , Neoplasias/mortalidade , Sistema de Registros , Estudos Retrospectivos , Fatores de Risco , Distribuição por Sexo , Taxa de Sobrevida , Fatores de Tempo
2.
Ann Ig ; 27(4): 633-45, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26241108

RESUMO

BACKGROUND: The places, where the incinerators are located, often present problems of heterogeneous people having different environmental factors. It becomes important to evaluate the possible etiologic role of various environmental risk factors and try to quantify as they affect in the excess epidemiological. METHODS: This study considers the ISTAT index mortality due to all causes occurred from 1988 to 2009 referred to ten municipalities at south of Vercelli (Piedmont, North Western Italy) placed nearby the active incinerator from 1977 (10 latent years). The risks were calculated considering this area at risk versus the municipalities placed at North of Vercelli and versus the Vercelli. RESULTS: Some significant statically excesses emerged in the South area such as neoplasia of nervous system, liver and total of tumours. CONCLUSIONS: The study presents some drawbacks, but it is a work creditable of widening by specific research ad hoc such as cohort and/or control where it is possible to verify various environmental, occupational and occasional factors.


Assuntos
Exposição Ambiental/efeitos adversos , Incineração , Mortalidade/tendências , Neoplasias/epidemiologia , Resíduos Sólidos , Feminino , Humanos , Itália/epidemiologia , Neoplasias Hepáticas/epidemiologia , Masculino , Neoplasias do Sistema Nervoso/epidemiologia , Centrais Elétricas , Fatores de Risco , Distribuição por Sexo , Fatores de Tempo
3.
Ann Ig ; 26(2): 157-66, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24763448

RESUMO

BACKGROUND: We performed a geographic analysis study on mortality in the town of Vercelli, in order to respond to the concerns of the population and some local administrators. Main reason to carry out a detailed and sophisticated study for a city of medium-small size was represented by the presence of various sources of environmental and industrial pressure (i.e. old-generation incinerator for solid urban waste, industrial site for chemicals production, intense agricultural activity of rice production…). METHODS: The study analyzed census, ISTAT death cards, both from the epidemiological point of view with admirers that SMR standardized spatial analysis using Bayesian models. RESULTS: Overall, both approaches highlighted major risks for the area south of the capital for major cancers such as colorectal and lung and increases worthy of investigation for the young-adult age groups in both genders. And being processed a similar study that considers the incidence oncology. CONCLUSIONS: The imminent elaboration of the cartography by oncological incidence will allow us to confirm, or less, the areas in excess for the death data, and in the meanwhile observe any excesses for low mortality pathologies (e.g., thyroid) or neoplasies whose present therapies allowed complete recovery and/or very long survivals (e.g. leukaemia, lymphomas and testicle).


Assuntos
Exposição Ambiental/efeitos adversos , Neoplasias/etiologia , Neoplasias/mortalidade , População Urbana/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Pré-Escolar , Feminino , Humanos , Indústrias , Lactente , Recém-Nascido , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Fatores de Risco , Saúde da População Urbana
4.
Arch Esp Urol ; 45(6): 541-4, 1992.
Artigo em Espanhol | MEDLINE | ID: mdl-1510493

RESUMO

The surgical approach for stone disease has completely changed during the last decade. Since 1980, ESWL and Endourology (percutaneous nephrolithotomy, ureteroscopy) have been used worldwide in the treatment of nephrolithiasis and today open surgery is necessary only in less than 5% of the cases. The second generation Wolf Piezolith 2300 is a lithotripter for the painless treatment of the majority of renal and ureteral stones. Treatment of stone patients on an out patient basis in a private clinic commenced in 1988 because of the low complications and side effects related to its use. We report the records of the first 70 patients treated in this way and controlled for at least 3 months after the treatment.


Assuntos
Assistência Ambulatorial , Cálculos Renais/terapia , Litotripsia , Cálculos Ureterais/terapia , Humanos
7.
J Urol ; 136(3): 624-31, 1986 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2942707

RESUMO

Patients with previously untreated category T3 to T4 Mo or Ml prostatic cancer were allocated randomly to receive 250 mg. cyproterone acetate per day, a loading dose of 500 mg. medroxyprogesterone acetate intramuscularly 3 times weekly for 8 weeks followed by 100 mg. orally twice daily, or 1 mg. diethylstilbestrol 3 times daily in a phase III trial (protocol 30761) performed by the genitourinary tract cooperative group of the European Organization for Research on the Treatment of Cancer. Of 236 patients entered 210 were eligible: 75 received cyproterone acetate, 71 medroxyprogesterone acetate and 64 diethylstilbestrol. Local and distant tumor response, time to progression, survival and toxicity were assessed. Patients treated with medroxyprogesterone acetate had a less favorable course with a shorter duration of survival and time to progression than those treated with the other 2 drugs. There was no significant difference between diethylstilbestrol and cyproterone acetate. Cardiovascular side effects were reported more often in patients treated with diethylstilbestrol than in those treated with cyproterone acetate but severe and lethal cardiovascular toxicity was relatively low in all groups. Other side effects were negligible. Further studies are required to establish the influence of effective hormonal treatment upon survival.


Assuntos
Carcinoma/tratamento farmacológico , Ciproterona/análogos & derivados , Dietilestilbestrol/uso terapêutico , Medroxiprogesterona/análogos & derivados , Neoplasias da Próstata/tratamento farmacológico , Idoso , Neoplasias Ósseas/secundário , Carcinoma/mortalidade , Doenças Cardiovasculares/induzido quimicamente , Ensaios Clínicos como Assunto , Ciproterona/efeitos adversos , Ciproterona/uso terapêutico , Acetato de Ciproterona , Dietilestilbestrol/efeitos adversos , Europa (Continente) , Seguimentos , Humanos , Masculino , Medroxiprogesterona/efeitos adversos , Medroxiprogesterona/uso terapêutico , Acetato de Medroxiprogesterona , Pessoa de Meia-Idade , Neoplasias da Próstata/mortalidade , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...